A Phase I Clinical Trial of Combined Cryotherapy and Intra-tumoral Immunotherapy With Autologous Immature Dendritic Cells in Men With Castration Resistant Prostatic Cancer and Metastases to Lymph Nodes and/or Bone Pre or Post Chemotherapy

Trial Profile

A Phase I Clinical Trial of Combined Cryotherapy and Intra-tumoral Immunotherapy With Autologous Immature Dendritic Cells in Men With Castration Resistant Prostatic Cancer and Metastases to Lymph Nodes and/or Bone Pre or Post Chemotherapy

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2016

At a glance

  • Drugs ACT 2001 (Primary) ; Cyclophosphamide; Ipilimumab
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Acronyms CryoIT
  • Sponsors Alden Cancer Therapy II
  • Most Recent Events

    • 19 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 19 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 May 2017.
    • 20 May 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top